CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer
Clinical trial NCT03699319 · COMPLETED
Trial details
- NCT number
- NCT03699319
- Sponsor
- David Bajor, MD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-07
- Primary completion
- 2024-09-23
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.